Landmark analysis of the 2-year cumulative incidence of progression of IA. Analysis included only patients alive and well on day 30 after BMT or CBT (A) or PBSCT (B) according to whether or not patients developed aGVHD grades II to IV. n=14 patients. Tick marks indicated censored patients.